EP3453402
REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
12.1.2013EP published:
21.7.2021EP application number:
18183272.6
EPO information:
European Patent Register
Max expiry date:
11.1.2033
Title:
REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY
Timeline
Today
12.1.2013EP application
21.7.2021EP Publication
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, Waltham MA 02451, US
Name:
Puget Sound Blood CenterAddress:
921 Terry Avenue, Seattle, Washington 98104-1256, US
Inventor
Name:
JIANG, HaiyanAddress:
Belmont, MA Massachusetts 02478, US
Name:
LIU, TongyaoAddress:
Lexington, MA Massachusetts 02421, US
Name:
KRISHNAMOORTHY, SriramAddress:
Acton, MA Massachusetts 01720, US
Name:
JOSEPHSON, NeilAddress:
Seattle, WA Washington 98104-1256, US
Name:
GLENN, PierceAddress:
Cambridge, MA Massachusetts 02142, US
Priority
Number:
201261586103 PDate:
12.1.2012Country:
US
Number:
201261668961 PDate:
6.7.2012Country:
US
Classification
Categories:
A61K 38/21, A61K 38/37, A61K 39/00, A61K 47/68, C12Q 1/68, C07K 14/755, C12Q 1/6883, A61P 37/06